News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • ARS Pharmaceuticals shares traded down sharply after litigation headlines and cash-runway concerns.
  • Market observers say much of the downside appears priced in.
  • Analysts present a tactical long for traders willing to accept event and execution risk.
  • Recommended trade includes clearly defined entry, stop and target levels.
  • The trade assumes continued operations, near-term de-escalation of headline volatility, and limited dilution.
  • Primary risks remain additional dilution and litigation escalation.

Latest Articles

Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026

Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026

Fractyl Health, a clinical-stage metabolic therapeutics company focusing on obesity and type 2 diabetes treatments, announced it will report its second quarter 2026 financial results and provide business updates on August 10, 2026. The company is developing two key therapeutic candidates: Revita, a procedural therapy for weight maintenance after GL…

Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

Longeveron Inc., a clinical stage regenerative medicine biotech company, announced it will release its financial results for the second quarter of 2026 and hold a conference call to discuss business updates on August 12, 2026. The company is developing allogeneic mesenchymal stem cell therapies targeting serious conditions such as hypoplastic left …

Adeia Announces Second Quarter 2026 Financial Results

Adeia Announces Second Quarter 2026 Financial Results

Adeia Inc. announced its second quarter 2026 financial results showing $96 million in revenue, strong profitability with a 59% adjusted EBITDA margin, and $55 million in operating cash flow. The company signed multiple key multi-year license agreements including renewals with Google (YouTube TV) and new deals with RPX covering 10 e-commerce custome…

Ethos Reports Second Quarter Fiscal Year 2026 Financial Results

Ethos Reports Second Quarter Fiscal Year 2026 Financial Results

Ethos Technologies Inc. announced its second quarter fiscal 2026 financial results, showing impressive year-over-year revenue growth of 113% to $190 million. The company also reported significant growth in both its direct channel and third-party revenue streams. Net income reached $19.5 million with strong profit margins. Additionally, Ethos' board…

Powell Industries Announces Third Quarter Fiscal 2026 Results

Powell Industries Announces Third Quarter Fiscal 2026 Results

Powell Industries, a custom-engineered electrical equipment supplier, announced its Q3 Fiscal 2026 results showing a 9% revenue increase to $312 million, an 8% increase in net income to $52.2 million, and a record $934 million in new orders, including three mega orders from data center, petrochemical, and LNG markets. Backlog surged 69% year-over-y…

Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Crinetics Pharmaceuticals announced that Vertex Pharmaceuticals will acquire the company for approximately $10 billion. The agreement, approved by both boards, is expected to close in Q3 2026 pending regulatory and shareholder approvals. Crinetics reported strong second-quarter 2026 results including $24 million in net product revenue from its comm…

EverQuote Announces Second Quarter 2026 Financial Results

EverQuote Announces Second Quarter 2026 Financial Results

EverQuote, Inc. announced its Q2 2026 financial results, reporting a 25% year-over-year revenue increase to $195.1 million and net income of $19.2 million. The company achieved record adjusted EBITDA of $30.1 million, up 37% from the previous year. Growth was driven by both automotive and home and renters insurance verticals, with the latter increa…

onsemi Reports Second Quarter 2026 Results

onsemi Reports Second Quarter 2026 Results

ON Semiconductor announced its second quarter 2026 financial results, reporting $1.6 billion in revenue—a 9% year-over-year increase—with significant improvements in gross margin and earnings per share. The company highlighted strong demand, particularly in AI-driven applications, and expects AI data center revenue to more than double in 2026. The …

Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors

Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors

Mobia Medical, a Nasdaq-listed medical device company specializing in stroke recovery technologies, announced the appointment of Dr. Myriam Curet to its Board of Directors. Dr. Curet brings extensive clinical and leadership experience, including roles at Stanford University and Intuitive Surgical, enhancing the company's medical and governance expe…

Great Elm Capital Corp. (“GECC”) Schedules Second Quarter 2026 Earnings Release and Conference Call

Great Elm Capital Corp. (“GECC”) Schedules Second Quarter 2026 Earnings Release and Conference Call

Great Elm Capital Corp. (NASDAQ: GECC), a business development company, has scheduled the release of its financial results for the second quarter ending June 30, 2026, to be announced after market close on August 5, 2026. The company will host a conference call on August 6, 2026, to discuss the results, with an accompanying slide presentation avail…

AH Realty Trust Reports Second Quarter 2026 Results

AH Realty Trust Reports Second Quarter 2026 Results

AH Realty Trust reported second quarter 2026 results highlighting a GAAP net loss driven by non-recurring impairments but achieving stable FFO, as Adjusted of $0.14 per share. The company completed a transformative quarter through a $485 million multifamily portfolio sale, which facilitated a $460 million debt paydown and increased share repurchase…

Vertex Announces Second Quarter 2026 Financial Results

Vertex Announces Second Quarter 2026 Financial Results

Vertex, Inc. announced its financial results for Q2 2026, reporting total revenues of $204.0 million, representing a 10.5% year-over-year increase. Cloud revenues grew 17.9%, and adjusted EBITDA margin expanded to 25.0% from 20.8% the prior year. The company highlighted progress on its AI-First strategy, solid customer retention, and increased mome…

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Inspire Medical Systems announced its second quarter 2026 financial results, reporting $200.6 million in revenue and adjusted diluted EPS of $0.14. Despite a 7.6% revenue decline driven by U.S. reimbursement challenges, the company improved operating cash flow significantly to $23.2 million and increased gross margins. Inspire unveiled 'Project Hor…

Viper Energy, Inc., A Subsidiary Of Diamondback Energy, Inc., Reports Second Quarter 2026 Financial And Operating Results; Increases Base Dividend

Viper Energy, Inc., A Subsidiary Of Diamondback Energy, Inc., Reports Second Quarter 2026 Financial And Operating Results; Increases Base Dividend

Viper Energy, a subsidiary of Diamondback Energy, announced robust financial and operational results for Q2 2026, including increased production guidance and a 32% hike to its base dividend. The company continues to execute an opportunistic capital return strategy combining dividends and share repurchases, alongside accretive acquisitions to expand…